Infliximab for IgG4-Related Orbital Disease

Ophthalmic Plastic and Reconstructive Surgery
Faiz KarimJ A M van Laar

Abstract

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition with unclear pathophysiology. It may occur as a single organ disorder, but multiorgan presentation is common and can mimic several conditions. The preferred therapy consists of steroids, but definite maintenance strategy remains unclear. The authors describe a case of a 61-year-old woman, initially diagnosed with idiopathic orbital inflammation refractory to multiple immunosuppressive agents. The disease was complicated with epilepsy, vision loss, and trismus. Treatment with various immunosuppressive agents was unsuccessful. Eventually the patient was effectively treated with infliximab. This is the second case of IgG4-RD treated with a TNF-blocker documented in literature and the first description to demonstrate its superiority over steroid sparing agents. Although speculative, TNF-blockers might exert their effect in IgG4-RD by interfering with the possible overexpressed TNF alpha due to fibrosis in this disease. Treatment with infliximab appears a good alternative for refractory IgG4-RD. However, further studies are required to define the value of infliximab in IgG4-RD.

References

Apr 9, 2001·American Journal of Physiology. Renal Physiology·G GuoS Klahr
Jun 21, 2003·American Journal of Respiratory Cell and Molecular Biology·Masaki FujitaRobert J Mason
Aug 1, 2008·Arthritis and Rheumatism·Jörg H W DistlerOliver Distler
Sep 23, 2008·Ophthalmic Plastic and Reconstructive Surgery·Tiphaine MiquelRobin Dhote
Aug 31, 2010·Current Rheumatology Reports·Gabriela M Espinoza
Feb 10, 2012·The New England Journal of Medicine·John H StoneVikram Deshpande
May 17, 2012·Annals of the Rheumatic Diseases·Motohisa YamamotoYasuhisa Shinomura
May 19, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Vikram DeshpandeJohn H Stone
Sep 6, 2012·Ocular Immunology and Inflammation·Konstantinos BalaskasYan Guex-Crosier
Sep 12, 2012·Acta Ophthalmologica·Nicholas AndrewDinesh Selva
Feb 28, 2013·International Journal of Rheumatic Diseases·Warren Weng Seng FongJon Kah Choun Yoong
Sep 17, 2013·The Australasian Journal of Dermatology·Chris JalilianChan Y Cheah
Dec 3, 2013·Clinical Radiology·T J TanA S C Low
Sep 18, 2014·Clinical Neuropharmacology·Anastasia Orlova LorentzenKjell Heuser
Nov 19, 2014·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Motohisa YamamotoYasuhisa Shinomura
Dec 8, 2014·Lancet·Terumi KamisawaJohn H Stone
Jan 1, 2015·Circulation. Heart Failure·Clemens DuerrschmidSandra B Haudek
Mar 27, 2015·Arthritis & Rheumatology·A KhosroshahiUNKNOWN Second International Symposium on IgG4-Related Disease
Jun 3, 2015·Journal of Ophthalmic Inflammation and Infection·Cecilia S LeeP Kumar Rao

❮ Previous
Next ❯

Citations

Feb 9, 2019·Acta Ophthalmologica·Sanne E DetigerDion Paridaens
Aug 29, 2019·Journal of Dental Research·X HongH Y Yang
Sep 1, 2017·Current Opinion in Ophthalmology·Larissa Derzko-Dzulynsky
Jun 10, 2017·Current Opinion in Ophthalmology·Richard C Allen
Mar 25, 2020·International Ophthalmology Clinics·Jennifer Murdock, Eric A Steele
Apr 30, 2020·Rheumatology·Federica MaritatiAugusto Vaglio
Jul 13, 2017·Ophthalmic Plastic and Reconstructive Surgery·Sanjai JalajMichael Kazim
Jun 18, 2020·BMJ : British Medical Journal·Marco LanzillottaEmanuel Della-Torre
Mar 11, 2021·Expert Review of Clinical Immunology·Marco LanzillottaEmanuel Della-Torre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.